Aardvark Therapeutics, Inc. (AARD) › Capital ExpendituresAardvark Therapeutics, Inc. (AARD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2024: $109.0K2025: $95.0K$95.0K2024Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$95.0K-12.8%2024$109.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share